RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis
2007

RASSF1A Methylation and Expression in Kidney Tumors

Sample size: 90 publication Evidence: high

Author Information

Author(s): Inga Peters, Kristina Rehmet, Nadine Wilke, Markus A Kuczyk, Jörg Hennenlotter, Tyark Eilers, Stefan Machtens, Udo Jonas, Jürgen Serth

Primary Institution: Medizinische Hochschule Hannover, Hannover, Germany

Hypothesis

RASSF1A is involved in early tumorigenesis of renal cell carcinoma.

Conclusion

The study supports that RASSF1A hypermethylation in normal cells may precede tumor formation in renal cell carcinoma.

Supporting Evidence

  • Significantly increased methylation was found in tumor samples compared to normal tissues.
  • Immunohistochemical analysis revealed reduced expression of RASSF1A in most tumor samples.
  • Heterogeneous expression patterns of RASSF1A were detected in a subgroup of normal tubular epithelia.

Takeaway

This study looked at how a gene called RASSF1A behaves in normal and cancerous kidney tissues, finding that changes in this gene might help tumors start growing.

Methodology

The study used combined bisulfite restriction analysis (COBRA) and immunohistochemistry to analyze RASSF1A methylation and expression in paired kidney tissue samples.

Limitations

The study may not account for all factors influencing RASSF1A expression and methylation in kidney tissues.

Participant Demographics

{"mean_age":61,"males":34,"females":11}

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1476-4598-6-49

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication